Cardiac Tamponade Secondary to COVID-19

Mohammed F Dabbagh; Lindsey Aurora; Penny D'Souza; Allison J Weinmann; Pallavi Bhargava; Mir B Basir

doi:10.1016/j.jaccas.2020.04.009

Cardiac Tamponade Secondary to COVID-19

JACC Case Rep. 2020 Jul 15;2(9):1326-1330. doi: 10.1016/j.jaccas.2020.04.009. Epub 2020 Apr 23.

Authors

Mohammed F Dabbagh¹, Lindsey Aurora¹, Penny D'Souza¹, Allison J Weinmann², Pallavi Bhargava², Mir B Basir¹

Affiliations

¹ Heart and Vascular Institute, Henry Ford Hospital, Detroit, Michigan.
² Department of Infectious Disease, Henry Ford Hospital, Detroit, Michigan.

Abstract

A 67-year-old woman presented with upper respiratory symptoms and was diagnosed with coronavirus disease-2019 (COVID-19). She was found to have a large hemorrhagic pericardial effusion with echocardiographic signs of tamponade and mild left ventricular impairment. Clinical course was complicated by development of takotsubo cardiomyopathy. She was treated with pericardiocentesis, colchicine, corticosteroids, and hydroxychloroquine, with improvement in symptoms. (Level of Difficulty: Intermediate.).

Keywords: COVID-19; COVID-19, coronavirus disease-2019; ECG, electrocardiography; LDH, lactate dehydrogenase; LVEF, left ventricular ejection fraction; RR, reference range; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; TTC, takotsubo cardiomyopathy; TTE, transthoracic echocardiography; cTnI, cardiac troponin I; pericardial effusion; takotsubo cardiomyopathy; tamponade.

Publication types

Case Reports